Quality of reporting in systematic reviews of adverse events: systematic review

Ref ID 124
First Author L. Zorzela
Journal BMJ : BRITISH MEDICAL JOURNAL
Year Of Publishing 2014
URL http://www.bmj.com/content/348/bmj.f7668.abstract
Keywords • General medical
• Harms
• Cochrane
Problem(s) • Reliance on randomised controlled trials for harms / safety data
• Selective reporting of harms / safety / adverse events / side effects
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country Canada
Aim To assess the quality of reporting of harms in systematic reviews published in the Cochrane Database or the Database of Abstracts of Systematic Reviews from January 2008 to April 2011, and to determine the need for a reporting guideline specific for reviews of harms.
Level of Investigation Descriptive
Summary of Findings Only 59 of 309 included reviews (19%) included both clinical trials and observational studies. Only observational studies were included in 109 reviews (35%), case series or case reports were included in 24 (7%). Three of 13 Cochrane reviews (23%) included observational studies compared with 165 of 296 DARE reviews (55%). Almost one third of DARE reviews (26%) did not clearly define the adverse events reviewed, nor did they specify the study designs selected for inclusion in their methods section. Almost half of reviews (n=170) did not consider patient risk factors or length of follow-up when reviewing harms of an intervention. Of 67 reviews of complications related to surgery or other procedures, only four (5%) reported professional qualifications of the individuals involved.
Number of systematic reviews included 309
Number of eligible systematic reviews assessed 4644
Treatment impacted No
Treatment impacted description
Interpretation impacted Not Applicable
Interpretation impacted description